{"nct_id":"NCT00042679","title":"A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.","status":"COMPLETED","status_verified_date":"2006-07","start_date":"2002-06","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":null,"completion_date_type":null,"phases":["PHASE2"],"tickers":["LLY"]}